RSS   Newsletter   Contact   Advertise with us

Agenus appoints chief scientific officer

Staff writer | Lexington, Ma., USA | January 14, 2014
AgenusJanuary 14, 2014, Lexington, Ma., USA - Agenus Inc., a biotechnology company, announced the appointment of Robert B. Stein to the newly-created position of chief scientific officer.
Over the course of Dr. Stein’s career he’s played a key role in bringing eight drugs to the market. Dr. Stein has held a number of progressively responsible senior management positions including CSO & SVP of Research for Ligand Pharmaceuticals, EVP of Research & Pre-clinical Development for Dupont Merck, President and CSO for Incyte Pharmaceuticals, President of Roche Palo Alto and CEO of KineMed.

Dr. Stein spent the early part of his career at Merck, Sharp and Dohme Research Laboratories. He holds an MD and a PhD in Physiology & Pharmacology from Duke University.

 LATEST MOVES FROM Massachusetts